Seminars in Hematology
Volume 44 , Pages S2-S6 , April 2007

Evaluation of Iron Levels to Avoid the Clinical Sequelae of Iron Overload

  • Ali Taher

      Affiliations

    • Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
    • Corresponding Author InformationAddress correspondence to Professor Ali Taher, MD, Department of Internal Medicine, American University of Beirut, PO Box 11-0236, Beirut 1107 2020, Lebanon.
    • ,
  • David Nathan

      Affiliations

    • Dana-Farber Cancer Institute, Boston, MA.
    • ,
  • John Porter

      Affiliations

    • Department of Haematology, University College London, London, UK.

References 

  1. Porter J. Pathophysiology of iron overload. Hematol Oncol Clin North Am. 2005;19(suppl 1):7–12
  2. Porter JB. Practical management of iron overload. Br J Haematol. 2001;115:239–252
  3. Breuer W, Hershko C, Cabantchik ZI. The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci. 2000;23:185–192
  4. Ponka P, Lok CN. The transferrin receptor: Role in health and disease. Int J Biochem Cell Biol. 1999;31:1111–1137
  5. Kushner JP, Porter JP, Olivieri NF. Secondary iron overload. Hematology (Am Soc Hematol Educ Program). 2001;47–61
  6. Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999;341:1986–1995
  7. Piperno A. Classification and diagnosis of iron overload. Haematologica. 1998;83:447–455
  8. Gabutti V, Piga A. Results of long-term iron-chelating therapy. Acta Haematol. 1996;95:26–36
  9. Modell B, Matthews R. Thalassemia in Britain and Australia. Birth Defects Orig Artic Ser. 1976;1213–1229
  10. Modell B. Management of thalassaemia major. Br Med Bull. 1976;32:270–276
  11. Risdon RA, Flynn DM, Barry M. The relation between liver iron concentration and liver damage in transfusional iron overload in thalassaemia and the effect of chelation therapy. Gut. 1973;14:421
  12. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997;89:739–761
  13. Fung EB, Harmatz P, Madden J, et al. Progression of organ dysfunction in iron overloaded patients with β thalassemia and sickle cell disease. Blood. 2004;104(11):1683;abstr
  14. Shalitin S, Carmi D, Weintrob N, et al. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Eur J Haematol. 2005;74:93–100
  15. el Hazmi MA, Bahakim HM, al Fawaz I. Endocrine functions in sickle cell anaemia patients. J Trop Pediatr. 1991;38:307–313
  16. Costagliola DG, de Montalembert M, Lefrere JJ, et al. Dose of desferrioxamine and evolution of HIV-1 infection in thalassaemic patients. Br J Haematol. 1994;87:849–852
  17. de Monye C, Karcher DS, Boelaert JR, et al. Bone marrow macrophage iron grade and survival of HIV-seropositive patients. AIDS. 1999;13:375–380
  18. Clemente MG, Congia M, Lai ME, et al. Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C. J Pediatr. 1994;125:123–128
  19. Jensen PD. Evaluation of iron overload. Br J Haematol. 2004;124:697–711
  20. Liu P, Olivieri N. Iron overload cardiomyopathies: New insights into an old disease. Cardiovasc Drugs Ther. 1994;8:101–110
  21. Brittenham GM, Cohen AR, McLaren CE, et al. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol. 1993;42:81–85
  22. Angelucci E, Brittenham GM, McLaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. 2000;343:327–331
  23. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171–2179
  24. St Pierre TG, Clark PR, Chua-anusorn W, et al. Non-invasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood. 2005;105:855–861
  25. Porter JB, Abeysinghe RD, Marshall L, et al. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. Blood. 1996;88:705–713
  26. Cabantchik ZI, Breuer W, Zanninelli G, et al. LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol. 2005;18:277–287
  27. Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous β-thalassemia. N Engl J Med. 1994;331:574–578
  28. Telfer PT, Prestcott E, Holden S, et al. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol. 2000;110:971–977
  29. Bowen D, Culligan D, Jowitt S, et al. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. Br J Haematol. 2003;120:187–200
  30. Olivieri NF, Brittenham GM, Matsui D, et al. Iron-chelation therapy with oral deferiprone in patients with thalassemia major. N Engl J Med. 1995;332:918–922
  31. Olivieri NF. The β-thalassemias. N Engl J Med. 1999;341:99–109
  32. Jensen PD, Jensen FT, Christensen T, et al. Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: A study in adult patients with acquired anemias. Blood. 2003;101:91–96
  33. Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: A prospective study using T2* cardiovascular magnetic resonance. Br J Haematol. 2004;127:348–355
  34. Cohen AR, Galanello R, Pennell DJ, et al. Thalassemia. Hematology (Am Soc Hematol Educ Program). 2004;1934–1936
  35. Wood JC, Tyszka JM, Carson S, et al. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood. 2004;103:1934–1936
  36. Jensen PD, Jensen FT, Christensen T, et al. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: Indication of close relation between myocardial iron content and chelatable iron pool. Blood. 2003;101:4632–4639

PII: S0037-1963(07)00053-4

doi: 10.1053/j.seminhematol.2007.03.002

Seminars in Hematology
Volume 44 , Pages S2-S6 , April 2007

Article Tools

* Image Usage & Resolution